Page last updated: 2024-08-22

sodium arsenite and Leukemia, Myeloid, Acute

sodium arsenite has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JH; Kim, ES; Kim, S; Lee, YY; Park, BB; Won, YW; Yoon, JS1
Alvarez, EM; Blanco, GA; Cavaliere, V; Costantino, SN; Kornblihtt, L; Lombardo, T1

Other Studies

2 other study(ies) available for sodium arsenite and Leukemia, Myeloid, Acute

ArticleYear
Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
    International journal of oncology, 2015, Volume: 46, Issue:5

    Topics: Antimetabolites, Antineoplastic; Arsenites; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Real-Time Polymerase Chain Reaction; Sodium Compounds

2015
Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion.
    Toxicology and applied pharmacology, 2012, Feb-01, Volume: 258, Issue:3

    Topics: Antineoplastic Agents; Arsenites; Burkitt Lymphoma; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrogen Peroxide; Leukemia, Myeloid, Acute; Leupeptins; Reactive Oxygen Species; Sodium Compounds; Superoxides; Time Factors; U937 Cells

2012